Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography
Kh. Krause et al., Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography, NEUROSCI L, 285(2), 2000, pp. 107-110
Ten previously untreated adults with attention deficit hyperactivity disord
er (ADHD) were investigated before and after 4 weeks of treatment with a do
se of 3x5 mg methylphenidate/d by single photon emission computed tomograph
y (SPECT) with [Tc-99m]TRODAT-1, the first Tc-99m labelled SPECT ligand spe
cifically binding to the dopamine transporter (DAT). For semiquantitative e
valuation of the DAT, specific binding ([STR-BKG]/BKG) was calculated in th
e striatum (STR) with the cerebellum used as background (BKG). The patients
with ADHD presented with increased specific binding of Tc-99m-TRODAT-1 to
the DAT as compared with age and sex matched controls ([STR-BKG]/BKG 1.43 /- 0.18 vs. 1.22 +/- 0.05, P < 0.001). After treatment with methylphenidate
specific binding decreased in all patients ([STR-BKG]/BKG 1.02 +/- 0.23, P
< 0.001). Thus, for the first time it could be demonstrated using SPECT th
at methylphenidate lowers increased striatal DAT availability in adults suf
fering from ADHD. (C) 2000 Elsevier Science Ireland Ltd. All rights reserve
d.